Kromek Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Kromek Group heeft een totaal eigen vermogen van £49.4M en een totale schuld van £8.1M, wat de schuld-eigenvermogensverhouding op 16.4% brengt. De totale activa en totale passiva bedragen respectievelijk £70.2M en £20.8M.

Belangrijke informatie

16.4%

Verhouding schuld/eigen vermogen

UK£8.10m

Schuld

Rente dekkingsratio	n/a
Contant	UK£466.00k
Aandelen	UK£49.35m
Totaal verplichtingen	UK£20.84m
Totaal activa	UK£70.19m

Recente financiële gezondheidsupdates

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Aug 04

Recent updates

At UK£0.056, Is Kromek Group plc (LON:KMK) Worth Looking At Closely?

Oct 29

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Apr 20

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Sep 02

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

Jan 14

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( £24.1M ) KMK } overtreffen de korte termijn passiva ( £15.5M ).

Langlopende schulden: De kortetermijnactiva KMK ( £24.1M ) overtreffen de langetermijnschulden ( £5.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 15.5% ) KMK wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van KMK is de afgelopen 5 jaar gestegen van 9% naar 16.4%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: KMK heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of KMK voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.

Kromek Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Recent updates

At UK£0.056, Is Kromek Group plc (LON:KMK) Worth Looking At Closely?

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Price target increased by 9.8% to UK£0.28

New minor risk - Financial data availability

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Kromek Group plc (LON:KMK) Soars 46% But It's A Story Of Risk Vs Reward

Kromek Group plc, Annual General Meeting, Mar 04, 2024

Kromek Group plc Grants £1.3 Million Under Horizon Europe Guarant Scheme New Joint Project to Develop AI-Powered Radiation Sensor Powered by Artificial Intelligence

First half 2024 earnings released: UK£0.005 loss per share (vs UK£0.012 loss in 1H 2023)

Kromek Group plc to Report First Half, 2024 Results on Jan 30, 2024

New minor risk - Financial data availability

Kromek Group plc's (LON:KMK) Price In Tune With Revenues

Kromek Group plc, Annual General Meeting, Sep 28, 2023

Kromek Group plc Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £1.028219 million.

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £7 million.

Kromek Group plc's (LON:KMK) Revenues Are Not Doing Enough For Some Investors

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.005 loss in 1H 2022)

Price target decreased to UK£0.27

Less than half of directors are independent

Kromek Group plc, Annual General Meeting, Sep 28, 2022

Kromek Group plc announced that it has received £1.14 million in funding

Kromek Group plc announced that it has received £1.7 million in funding

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Full year 2022 earnings: EPS misses analyst expectations

Kromek Group plc Provides Earnings Outlook for the Year Ended 30 April 2022

Price target decreased to UK£0.38

Less than half of directors are independent

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Kromek Group plc Provide Earnings Guidance for the Year Ended April 30, 2021

Kromek Group plc Awards Nuclear Detection Contract

Kromek Wins Medical Screening and Nuclear Security Orders

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £10 million.

New 90-day high: UK£0.20

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

First half 2021 earnings released: UK£0.009 loss per share

Kromek Group plc Announces Funding to Advance Bio-Threat Detection Solution

Kromek Group plc Announces Management Changes

Kromek Group plc to Report First Half, 2021 Results on Jan 13, 2021

Kromek Group plc Launches the D5 RIID Radiation Detector

Rmd’S Cllbc Technology Successfully Integrated in Kromek’S Riid

Kromek Group plc Commences Development of A New System to Improve the Pathological Medical Imaging Techniques Used During Cancer Surgery

Full year earnings released

Annual earnings released: Revenue misses expectations

Kromek Group plc Appoints Rakesh Sharma Obe as A Non-Executive Director

Kromek Launches the D3 PRD High-Accuracy Personal Radiation Detector

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven